Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $96.0 million.

  • Veracyte's Net Cash Flow rose 15255.72% to $96.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.7 million, marking a year-over-year decrease of 4165.78%. This contributed to the annual value of $23.7 million for FY2024, which is 6183.91% down from last year.
  • As of Q3 2025, Veracyte's Net Cash Flow stood at $96.0 million, which was up 15255.72% from $32.8 million recorded in Q2 2025.
  • Veracyte's Net Cash Flow's 5-year high stood at $96.0 million during Q3 2025, with a 5-year trough of -$163.6 million in Q3 2021.
  • For the 5-year period, Veracyte's Net Cash Flow averaged around -$1.6 million, with its median value being $9.0 million (2021).
  • In the last 5 years, Veracyte's Net Cash Flow surged by 35273.7% in 2023 and then crashed by 66150.75% in 2025.
  • Veracyte's Net Cash Flow (Quarter) stood at $9.0 million in 2021, then plummeted by 284.33% to -$16.6 million in 2022, then soared by 182.55% to $13.7 million in 2023, then crashed by 349.1% to -$34.1 million in 2024, then skyrocketed by 381.29% to $96.0 million in 2025.
  • Its last three reported values are $96.0 million in Q3 2025, $32.8 million for Q2 2025, and -$52.9 million during Q1 2025.